|
|||||
|
|
Ustekinumab treatment is associated with decreased systemic and vascular inflammation in patients with moderate-to-severe psoriasis: Feasibility study using 18F-fluorodeoxyglucose PET/CT |
|
| Authors: | Byung-Soo Kim Won-Ku Lee Kyoungjune Pak Junhee Han Gun-Wook Kim Hoon-Soo Kim Hyun-Chang Ko Moon-Bum Kim Seong-Jang Kim |
| Affiliation: | 1. Department of Dermatology, School of Medicine, Pusan National University, Busan, Korea;2. Biomedical Research Institute, Pusan National University Hospital, Busan, Korea;3. Department of Dermatology, Pusan National University Yangsan Hospital, Yangsan, Korea;4. Research Institute for Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital, Yangsan, Korea;5. Department of Nuclear Medicine, Pusan National University Hospital, Busan, Korea;6. Department of Statistics, Hallym University, Chuncheon, Korea;7. Department of Nuclear Medicine, College of Medicine, Pusan National University, Busan, Korea;8. Department of Nuclear Medicine, Pusan National University Yangsan Hospital, Yangsan, Korea |
| Abstract: | |
| Keywords: | cardiovascular disease metabolic syndrome PET/CT positron emission tomography–computed tomography psoriasis ustekinumab BMI body mass index BSA body surface area CVD cardiovascular disease PASI Psoriasis Area and Severity Index PASI75 75% improvement from baseline Psoriasis Area and Severity Index score Reprint requests: Seong-Jang Kim, MD, PhD, Department of Nuclear Medicine, School of Medicine, Pusan National University, Geumo-ro 20, Mulgeum-eup, Yangsan, Gyeongsangnam-do 626-770, Republic of Korea. |
| 本文献已被 ScienceDirect 等数据库收录！ | |